Objectives: To evaluate differences in radiation dose and image quality across institutions, fluoroscope vendors and generations of fluoroscopes for pediatric cardiac catheterization.
| INTRODUCTION
In children with heart disease, fluoroscopically guided cardiac procedures account for more cumulative ionizing radiation exposure than all other imaging procedures combined. [1] [2] [3] Children are more sensitive to the harmful effects of ionizing radiation due to their increased tissue sensitivity, and longer anticipated lifespan during which harmful effects can accrue. [4] [5] [6] For these reasons, stakeholders, including interventional pediatric cardiologists and fluoroscope manufacturers, are increasingly recognizing the critical importance of improving radiation safety during fluoroscopically guided procedures. 4, [7] [8] [9] [10] [11] Increased recognition has led to new advances in fluoroscopic hardware and
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software aimed at reducing radiation dose, as well as increased attention to equipment and procedural optimization to facilitate lower dose imaging in children.
While breakthroughs in dose reduction have undoubtedly improved the safety of pediatric fluoroscopically guided cardiac procedures, there will always be an inverse relationship between radiation dose and image quality. Efforts to reduce radiation dose should not impact image quality to an extent that compromises either diagnostic capability or procedural safety. 9 Currently, there are no universally accepted practice standards dictating appropriate image quality during pediatric cardiac catheterization, and there is little understanding of variability in the dose-image quality relationship across institutions, equipment vendors or even generations of fluoroscopy equipment.
Our objective was to better understand variability in the various image quality and radiation dose parameters. Using dose-assessment and image quality phantoms, we evaluated image quality and radiation 2 | METHODS institutional assessment at a pediatric institution with a recent installation of the GE Innova IGS fluoroscopy system. As part of the conditions of the assessment, engineers at the testing laboratory agreed in advance to the dose and image quality testing parameters that we stipulated and allowed our investigator to independently verify the system setup including the use of an ion chamber to confirm that appropriate kerma values were reported.
| Fluoroscopic systems and institutions

| Dose assessment
An ATOM family anthropomorphic phantom (CIRS, Norfolk, VA)
representing a newborn (51 cm, 3.5 kg, thorax dimension 9 × 10.5 cm) was used for dose simulations. This phantom is designed specifically for radiation dose assessment and is manufactured using tissue/organ equivalent epoxy resins (including bone density formulated to represent the appropriate bone age of the phantom) with linear attenuation within 1% for bone and soft tissue and 3% for lung tissue at photon energies from 30 keV to 20 MeV.
Testing of the various fluoroscopes was performed using the fluoroscopic hardware and configuration specifications in clinical use at the various institutions at the time of evaluation. For all systems, we used the lowest available dose mode and we tested the neonatal imaging parameters previously configured for each system. We did not make any attempt to optimize the various fluoroscopes beyond their already configured "clinical setup." As the GE fluoroscope was tested at the GE testing laboratory, we relied upon the hardware and software configuration of the system without further optimization. For all imaging, a "standard operating technique" was defined. A baseline phantom image was recorded at our first institutional assessment and this image was replicated at each of the remaining institutions to ensure an identical imaging field-of-view. The phantom was positioned at the imaging isocenter and cameras were positioned by a trained pediatric interventional cardiologist to optimally simulate typical imaging views.
Peripheral collimators were used for all of the imaging sequences to limit scatter effects and to fine tune the imaging field of view.
Collimators were set to the same width for all imaging using the baseline phantom image as a reference. We used similar magnifica- (2) beam position over the thorax, (3) source to subject distance, (4) subject to receptor distance, (5) camera angles, (6) spectral filtration (e.g., copper, aluminum), and (7) 
| Image quality assessments at standardized effective dose
To compare image quality of the latest generation systems at relatively comparable doses, we performed phantom imaging using different fluoroscopic and cineangiographic imaging modes (i.e., by manipulating the preprogrammed dose modes for each fluoroscope). Effective doses for each of these images were calculated using the same approach as summarized above. We then selected image acquisitions for each fluoroscope with similar doses per pulse/frame. Still frames images for these acquisitions were scored by the blinded reviewers using the same objective approach outlined above (minimum percent contrast and line space differentiation). Reviewers also provided a separate subjective ranking of image quality for the dosimetry phantom based on their visual assessment of the still frame image.
| Institutional variability
Assessments summarized above use standardized frame rates 
| Statistical analysis
Statistical analysis was performed using SPSS 22.0 (IBM, Chicago, IL).
Continuous data are presented as mean AE 1 SD. For effective dose estimates, and error % was reported to represent statistical uncertainty from the Monte Carlo simulation. Correlations between variables were determined using the Spearman rank order correlation coefficient.
Cronbach's alpha test was used to assess inter-rater reliability between the three image quality reviewers. All tests of significance were twotailed; a P value of <0.05 was considered to indicate significance.
3 | RESULTS pulses across all four vendors. In contrast, the older generation Phillips Allura system had 2.0-to 3.5-fold higher doses (0.14 mSv/1,000 pulses). For acquisitions, dose rates for the newer generation systems ranged more widely from 0.17 mSv/1,000 frames for the Phillips Clarity system to 0.52 mSv/1,000 frames for the Toshiba Ultimax system (notably the Toshiba Ultimax system had the highest image quality score, see below for more details). Once again dose rates for the older generation Phillips Allura system were higher than all of the other systems at 0.57 mSv/1,000 frames. were not entirely related to differences in delivered dose.
| Effective dose and image quality
| Institutional variability
In general, institutions reported using similar baseline imaging frame rates and magnification settings ( Table 3 ). The two exceptions were:
(1) institution C (Toshiba Ultimax) preferred fluoro-save mode instead of cineangiography for neonatal acquisitions; and (2) institution A used pulse and frame rates of 15 per second with their older generation Phillips Allura system as the system was not programmed to permit lower pulse/frame rates. Simulated diagnostic catheterization procedures (20 min of fluoroscopy time + four biplane acquisitions) are summarized in Figure 1 . For latest generation systems, procedural doses were very low, ranging from 0.29 to 0.48 mSv. However, the estimated procedural dose for the older generation Phillips Allura Xper system was substantially higher at 2.81 mSv. This increased dose reflects both increased dose per pulse/frame, as well as higher procedural pulse/frame rates.
| Image quality comparisons at standardized effective dose
Selected acquisitions with similar doses per pulse/frame rate (range 1.7 to 2.6 × 10 −4 mSv), and associated doses/image quality scores are displayed in Figure 2 . Objective evaluation of contrast detail and line per square inch differentiation were relatively similar across the four vendors ( Figure 2 ). The Allura Clarity system had the highest objective evaluation, however, all three reviewers subjectively considered the Toshiba Ultimax image as the highest quality followed by the Allura Clarity, GE Innova and then the Siemens Artis. Reviewers agreed that there was little difference in image quality across the four systems. a Data provided represent the typical baseline imaging parameters at each institution for neonatal imaging. All institutions vary imaging approaches depending on procedural objectives. * Testing performed at the GE testing laboratory. Imaging parameters were imputed based on typical parameters used at the other institutions.
| DISCUSSION
This is the first analysis comparing variability in radiation dose and image quality across institutions and vendors for fluoroscopes used for pediatric cardiac catheterization. The most striking finding is the substantial reduction in dose achieved with the newer generation fluoroscopy systems when compared to the older generation Phillips Allura Xper system. While there was also some variability across vendors when comparing the newer generation systems, the differences were relatively smaller and may be partially or completely related to institutional system optimization rather than differences in hardware performance.
The doses that we estimate for a simulated cardiac catheterization procedure using the latest generation fluoroscopes Table 3 ) were used to estimate effective dose for a simulated procedure consisting of 20 min of fluoroscopy time + four biplane acquisitions. Dose estimates reflect both hardware performance as well institutional optimization processes. For example, the institution using the older generation Phillips Xper system uses higher frame rates, while the institution using the Toshiba Ultimax system uses fluoro-save mode for acquisitions instead of cineangiography. Testing for the GE system was performed at the GE testing lab and imaging parameters were chosen by investigator consensus FIGURE 2 Comparison of image quality at standardized effective doses. Four image acquisitions with similar doses per pulse/frame (1.7-2.6 × 10 −4 mSv) were scored by blinded reviewers. Reviewer scores reflect objective assessment of the image quality phantom (lower panel)
with respect to the minimum percent contrast visible to the reviewer, and the maximum line space resolution (measured in lines per square inch). A lower objective score for both variables represents better image quality. Reviewers were also asked to subjectively rate image quality for a still frame thoracic image of the dosimetry phantom (upper panel). For this latter score, the images are rated from best (#1) to worst (#4) software algorithms, but also dose reductions of~2-fold due to lower pulse/frame rates with the newer generation systems. Of note, it is feasible to use lower pulse/frame rates with the older generation Phillips Allura system but there was no configured mechanism for doing this on the system that we tested. In contrast, the newer generation systems all incorporate easy to use toggles to accommodate rapid switching between a wider range of pulse/frame rates. Taken together, the hardware/software advances of latest generation systems, as well as their more user-friendly optimization features, result in the substantial reductions in radiation dose that we report. Our data may be useful to providers using older generation technology as a means to justify institutional fluoroscope upgrades.
When comparing the latest generation fluoroscopes across vendors, there were smaller, but nonetheless meaningful differences in both dose and image quality. These differences accurately reflect site variability in system performance but, without knowledge of the proprietary hardware specifications and software configurations for any given system, it is difficult to know if this is due to hardware performance versus differences in system optimization. Fluoroscope optimization is critically important in dose management, particularly for fluoroscopes used for pediatric imaging. It is also notable that there was substantial variability in image quality across institutions. In 2001, a working group convened by the Society for Cardiac Angiography and Interventions (SCAI) provided recommendations for phantom-based image quality assessment of fluoroscopes. 15 We followed the recommended approaches for our assessments and our data provide the first published estimates of image quality for pediatric cardiac catheterization. Unfortunately, there are no current image quality standards or benchmarks that providers can reference when optimizing their imaging systems. Image quality is always in the "eye of the beholder." Nonetheless, it would be helpful if providers could reference benchmark data to guide system set-up. Our data from only three institutions are not sufficient, but may provide a useful starting point.
Finally, it is reassuring that when using latest generation equipment, a procedure with 20 min of fluoroscopy time and four biplane cineangiograms can be performed with effective doses substantially below 0.5 mSv. At a recent NIH-NHLBI/NCI-sponsored think tank evaluating dose thresholds for cardiac imaging, doses ≤3 mSv were deemed "very low". 16 Indeed the estimated annual background radiation exposure to an individual living in the United States is 3 mSv. 17 Nonetheless, providers should remain vigilant in their efforts to reduce ionizing radiation exposure as our testing was performed under optimized imaging conditions (collimated, low magnification settings, low camera height, etc.). We have previously demonstrated that failure to optimize imaging approach during cardiac catheterization can increase procedural doses by up to eightfold. 18 It is also important to note that the harmful effects associated with a given dose are substantially increased in a neonate when compared to an adult. 17 Strengths of our study include the use of a standardized process and approach for dose estimation and image quality assessment. By using an anthropomorphic phantom specifically designed for radiation dose estimation, we were able to tightly control imaging conditions for the most accurate comparisons across institutions. Moreover, our blinded assessment of image quality ensures the most fair and unbiased approach. However, we do acknowledge that our blinded scoring system has not been previously validated in any formal research setting although it is reassuring that inter-rater reliability between the three reviewers was good to excellent with an overall reliability score of 0.87 (95% CI 0.72-0.94). There are also several additional limitations to our approach. Most notably, we relied upon the typical institutional approach to imaging without any standardization of hardware/software imaging parameters. This allows a comparison of approaches across institutions but limits ability to identify the "best"
vendor or fluoroscopic equipment. Our comparisons of institutional variability are also limited as we relied on "typical" imaging parameters from the respective institutions. Operators will often adjust their imaging approach depending on procedural conditions, and our methodology does not capture the influence of these "operator-dependent" manipulations on institutional variability. We also limited our assessment to neonatal phantom imaging. This was purely for practical reasons as the older phantoms are bigger and extremely difficult to transport between institutions. It is possible that our findings are specific to neonatal imaging and do not reflect imaging in older children and adolescents. Certainly, these findings should not be applied to adults as system optimization will be vastly different. Additionally, the image quality measurements were conducted without anatomical (structural) noise and with simplistic targets, which may not adequately differentiate the benefits of advanced image processing across systems. Our image quality details were limited to anatomic imaging and did not consider factors such as device visibility which can be critically important for procedural safety. Indeed device manufacturers are increasingly recognizing this and designing devices so as to augment fluoroscopic visibility. Finally, we evaluated equipment at only three institutions and a testing laboratory. The travel and testing burden associated with these analyses was substantial and limited testing at additional sites. Although our testing at the GE laboratory does not represent typical "practice," GE engineers did agree to a subset of baseline testing parameters (e.g., we used an ion chamber to verify system-reported dose rates) and we performed the phantom imaging under standardized conditions to prevent any unfair manipulation of the fluoroscope performance. It is also notable that fluoroscopic vendors are continuously evolving their imaging equipment and the "latest generation" equipment that we tested is already being replaced with newer models (e.g., the Phillips Azurion line was recently launched worldwide).
In conclusion, in our analysis of institutional, vendor-specific and generational differences in fluoroscope performance for pediatric cardiac catheterization, we found that newer generation systems substantially outperform a system considered "state of the art" only a decade ago. We also noted meaningful differences in institutional dose and image quality. Although we are unable to delineate whether these differences represent hardware and/or software related differences across vendors versus differences in institutional optimization approaches, the differences are meaningful and highlight the need for further study.
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